News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • No major economic data or corporate earnings released in the past hour, leaving markets directionless.
  • U.S. equity futures and European cash markets traded with low volume and narrow ranges.
  • Treasury yields showed minimal movement, keeping fixed-income markets steady.
  • Dollar index was largely unchanged, offering little currency-driven market impetus.
  • No fresh geopolitical incidents reported in the past hour to affect risk sentiment.
  • Political calendar quiet with no new policy announcements from major central banks or governments.

Latest Articles

Tenax Therapeutics Announces Topline Results from Phase 3 LEVEL Clinical Trial of TNX-103 in Patients with PH-HFpEF

Tenax Therapeutics Announces Topline Results from Phase 3 LEVEL Clinical Trial of TNX-103 in Patients with PH-HFpEF

Tenax Therapeutics announced topline results from its Phase 3 LEVEL trial evaluating oral levosimendan (TNX-103) in patients with pulmonary hypertension associated with heart failure with preserved ejection fraction (PH-HFpEF). The study did not meet its primary endpoint of improvement in 6-minute walk distance or the key secondary endpoint of symp…

Grifols Announces Last Patient Last Visit in SPARTA, its Phase 3 Outcomes Study of Prolastin®-C in Patients With Emphysema Due to Alpha-1 Antitrypsin Deficiency

Grifols Announces Last Patient Last Visit in SPARTA, its Phase 3 Outcomes Study of Prolastin®-C in Patients With Emphysema Due to Alpha-1 Antitrypsin Deficiency

Grifols announced the completion of the clinical portion of its SPARTA Phase 3 trial evaluating two dosage regimens of Prolastin®-C in patients with emphysema caused by alpha-1 antitrypsin deficiency (AATD). The trial enrolled 345 patients across 16 countries and utilized lung CT densitometry as the primary endpoint. The results are expected by the…

Ceribell Receives FDA Clearance for Advanced Epileptiform Abnormality Detection and Artifact Reduction for Its Cloud-Based Portal, Delivering Greater Precision for Critical-Care EEG Review

Ceribell Receives FDA Clearance for Advanced Epileptiform Abnormality Detection and Artifact Reduction for Its Cloud-Based Portal, Delivering Greater Precision for Critical-Care EEG Review

Ceribell, Inc., a medical technology firm specializing in neurological diagnostics, announced FDA 510(k) clearance for two new AI-driven features—Epileptiform Abnormality Detection and Artifact Reduction—integrated into its cloud-based Neurology Portal. These enhancements improve the accuracy and efficiency of EEG evaluations in critical care setti…

Soft July Jobs Print, Oil and Political Pressure Keep Markets on Edge

Soft July Jobs Print, Oil and Political Pressure Keep Markets on Edge

A surprising drop in July payrolls failed to trigger a decisive move in interest rate markets, where investors still place roughly even odds on a Federal Reserve rate increase next month. That restraint reflected a mix of factors including a fall in the unemployment rate, higher oil prices, fresh political pressure on a Fed governor, heavy Treasury…

Veru Reports Fiscal 2026 Third Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress

Veru Reports Fiscal 2026 Third Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress

Veru Inc. reported its fiscal third quarter 2026 financial results, highlighting full enrollment of 239 patients in its Phase 2b PLATEAU clinical trial evaluating enobosarm in combination with semaglutide for high quality weight loss in older obese patients. The company entered a clinical supply agreement with Novo Nordisk and received a USPTO noti…

Aeries Technology Reports Strong Results for April

Aeries Technology Reports Strong Results for April

Aeries Technology, Inc. reported strong first-quarter fiscal 2027 results with a 43% year-over-year revenue increase to $21.9 million, significant improvements in profitability, and operating cash flow of $4.8 million. The company reaffirmed its fiscal year 2027 guidance and launched AxAI, an agentic AI solution, expanding its AI transformation str…

AirSculpt Technologies Reports Second Quarter Fiscal 2026 Results

AirSculpt Technologies Reports Second Quarter Fiscal 2026 Results

AirSculpt Technologies, a NASDAQ-listed company specializing in premium body contouring procedures, reported its second quarter and first half fiscal 2026 results. The company demonstrated stable same-center case volumes with a slight revenue decline and net loss increase compared to the prior year. Strategic investments were made in marketing and …

Barrick Reports Second Quarter 2026 Results

Barrick Reports Second Quarter 2026 Results

Barrick Mining Corporation announced robust second quarter 2026 results, including 796,000 ounces of gold production, exceeding guidance, and a net earnings increase of 50% year-over-year. The company reached a significant agreement with Newmont expanding the Nevada Gold Mines Joint Venture, resulting in a $1.95 billion cash top-up and Newmont’s co…

Barrick Declares Q2 Dividend

Barrick Declares Q2 Dividend

Barrick Mining Corporation announced a quarterly dividend of $0.175 per share for Q2 2026, maintaining its dividend policy targeting a 50% payout of free cash flow annually. The dividend will be paid on September 15, 2026 to shareholders of record on August 31, 2026. The company reiterates its focus on responsible mining and long-term value creatio…

Red Cat Announces Multiyear Partnership with Washington Commanders to Support America's Military Community

Red Cat Announces Multiyear Partnership with Washington Commanders to Support America's Military Community

Red Cat Holdings, Inc., a U.S. provider of advanced drone and robotic solutions for defense, announced a multiyear partnership with the NFL's Washington Commanders. This collaboration focuses on military appreciation initiatives including community events and in-stadium branding throughout the upcoming season, reflecting Red Cat's commitment to sup…

NVIDIA Is Packaging AI Complexity Into a Durable, Compounding Moat

NVIDIA Is Packaging AI Complexity Into a Durable, Compounding Moat

Nvidia has turned the messy economics and engineering overhead of AI into a product-led moat. Exceptional margins, huge free cash flow and tight competitive differentiation justify paying up, but the valuation leaves little margin for cyclical weakness. This trade targets a measured long exposure with a mid-sized position, defined stop and a 34% up…

EH216-S Completes Central Asia’s First Pilotless Human-Carrying eVTOL Flight in the Heart of Kazakhstan’s Capital

EH216-S Completes Central Asia’s First Pilotless Human-Carrying eVTOL Flight in the Heart of Kazakhstan’s Capital

EHang Holdings Limited announced that its flagship electric vertical takeoff and landing (eVTOL) aircraft, the EH216-S, successfully completed Central Asia’s first pilotless human-carrying flight in Astana, Kazakhstan. The flight demonstrated EHang’s capabilities under Kazakhstan's newly established regulatory framework, highlighting partnerships f…

Buy Meta Now and Let FCF Catch Up: A 180-Day Trade for Patient Bulls

Buy Meta Now and Let FCF Catch Up: A 180-Day Trade for Patient Bulls

Meta is investing aggressively in AI infrastructure, which suppresses near-term free cash flow. With $40.98B in trailing free cash flow, a $1.51T market cap and attractive operating returns, the company is positioned to produce a sharp FCF recovery once capex cools and AI monetization scales. This trade idea outlines a pragmatic long (buy) with ent…

Barclays: China’s July Export Surge Fueled by AI Hardware and Green Tech

Barclays: China’s July Export Surge Fueled by AI Hardware and Green Tech

Barclays' analysis of July trade figures shows China’s exports rose 23.9% year-over-year, beating the 23.0% Bloomberg consensus. Growth was concentrated in AI-related products and green technology, while labor-intensive and low-tech sectors continued to underperform, leaving potential pressures on the labor market despite an expanded trade surplus.